Collections:
Other Resources:
DOI: 10.1182/blood.2021014689
Paper Summary:
Title: Asciminib: new therapeutic option in chronic phase CML with treatment failure.
Author(s): Yeung, David T; Shanmuganathan, Naranie; Hughes, Timothy P
Year: 2022
DOI: 10.1182/blood.2021014689
URL: https://doi.org/10.1182/blood.2021014689
Received on: 2022-10-26
✍: FYIcenter.com
2022-10-26, ∼1240👍, 0💬
Related Topics:
Popular Posts:
Paper Summary: DOI: 10.4324/9781003266532 Received on: 2024-05-04
Paper Summary: DOI: 10.1038/s41366-023-01402 -5Received on: 2023-11-29
Paper Summary: Title: An ethnographic study of visual impairments for voice user interface design Au...
Paper Summary: DOI: 10.1016/j.evalprogplan.2 023.102317Received on: 2024-05-21
Paper Summary: Title: Prevalence and correlates of comorbid depression in a nonclinical online sampl...
